ABSTRACT
OBJECTIVE@#To assess the analgesic efficacy of compound lidocaine cream in lumbar puncture of children with leukemia and lymphoma.@*METHODS@#312 leukemia and lymphoma children necessarily undergone lumbar puncture were divided into compound lidocaine cream (cream) group and compound lidocaine injection (injation) group as control with 156 cases respectively according to the will of inpatient children and their family. For cream group, compound lidocaine cream was smeared on the skin around the lumbar puncture point evenly and covered with sterile and transparent dressing for about one hour before lumbar puncture. Then the cream and transparent dressing were removed and lumbar puncture was performed after regular disinfection. For control group, 2% compound lidocaine was injected as local anesthesia before lumbar puncture. The extent of pain was evaluated by Wong-Baker Faces Pain Rating Scale and FLACC Scale as well as children's physiological indexes (heart rate, breathing, blood pressure). The lumbar puncture success rate and the discomfortableness as well as family satisfaction were recorded by special person.@*RESULTS@#Compared with control group, the incidence of pain and discomfortableness in cream group significantly reduced, and the family satisfaction significantly increased (P＜0.05). There were obviously differences in the physiological indexes (heart rate, breathing, systolic blood pressure) before and after lumbar puncture in control group (P＜0.05). However, the physiological indexes in cream group had no obvious change. There was no difference on the success rate of lumbar puncture between the two methods of anesthesia.@*CONCLUSION@#Compound lidocaine cream has significantly analgesic effect which can relieving pain caused by lumbar puncture for children.
Subject(s)
Child , Humans , Analgesics , Anesthetics, Local , Hematologic Neoplasms , Lidocaine , Lidocaine, Prilocaine Drug Combination , Spinal PunctureABSTRACT
Retinal vein occlusion (RVO) is the second common retinal vascular disease after diabetic retinopathy,which is divided into central retinal vein occlusion and branch retinal vein occlusion (BRVO).The current specific pathogenisis of BRVO is remain unclear and the incidence rate has been increases year by year.BRVO often causes macular edema (ME),and recurrent ME can lead to a permanent decline in vision.Traditional treatment includes grid laser photocoagulation and glucocorticoid drugs represented by traimcinolone and dexamethasone.In recent years,anti-vascular endothelial growth factor drugs and vitrectomy have developed,and become new treatment methods for BRVO.This paper will give a review on the recent advances in the treatment methods of BRVO.
ABSTRACT
The application of sutureless minimally invasive vitrectomy has been used for more than 10a.High-speed cutting and fine instrumentation have been effective in the treatment of severe vitreoretinal diseases,but intraoperative and postoperative complications have also seriously affected vision recovery,including choroidal detachment is minimally invasive vitrectomy and postoperative relatively rare complications,secondary glaucoma,decreased vision,etc.The reasons and treatment of choroidal detachment during and after minimally invasive vitrectomy are summarized below.
ABSTRACT
<p><b>OBJECTIVE</b>To assess the safety and therapeutic effect of morcellator in transurethral bipolar plasmakinetic anatomical enucleation (TUPKAEP) of benign prostate hyperplasia (BPH).</p><p><b>METHODS</b>The clinical data of 47 patients with BPH receiving TUPKAEP between January and July, 2015 were analyzed. During the operation, morcellator was used to smash the enucleated BPH which was aspirated with subatmospheric pressure in 29 cases, and the tissue was smashed with bipolar electrosurgical loop slicing from top to bottom and aspirated by ellic suction in 18 cases.</p><p><b>RESULTS</b>s The procedures were completed successfully in all the 47 cases. The time used for adenoma dissociation was 2.24∓1.09 with morcellator at the speed of 18.43∓6.01 g/min, and was 17.19∓11.74 min with bipolar electrosurgical loop at the speed of 1.91∓0.65 g/min; the mean total operation time was significantly shorter in morcellator group (28.13∓14.71 vs 43.22∓25.39 min). The 2 groups showed no significant difference in postoperative continuous bladder irrigation time, postoperative indwelling time of urinary catheter or postoperative hospital stay.</p><p><b>CONCLUSION</b>s Morcellator is safe and feasible for application in TUPKAEP and helps to shorten the operation time.</p>